Skip to main content
. 2020 Nov 16;28(e1):e128–e133. doi: 10.1136/ejhpharm-2020-002492

Table 1.

Characteristics of the study population

Total population, n=719
Age, mean (SD), years 81 (10)
Sex, n (%) male 345 (48)
Housing before admission (%)
 Home without homecare 403 (56)
 Home with homecare 169 (24)
 Nursing home 146 (20)
Length of stay, median days (IQR)
 In the hospital 10 (6–16)
 In the ward 8 (5–14)
No of drugs, median (IQR)
At admission
 Continuous use 7 (5–11)
 As needed 1 (0–2)
At discharge
 Continuous use 8 (5–11)
 As needed 2 (1–3)
During the hospital stay
 Initiated 2 (1–4)
 Stopped 1 (0–3)
Renal function reduction, n (%)*
 No reduction 84 (11.7)
 Mild, GFR 60–89 mL/min 157 (21.8)
 Moderate, GFR 30–59 mL/min 313 (43.5)
 Severe, GFR 15–29 mL/min 115 (16.0)
 Kidney failure, GFR <15 mL/min 14 (1.9)
 No information 36 (5.0)
Drug allergy or hypersensitivity documented in the EHR, n (%) 133 (18.5)

*Renal function was calculated using the Cockroft-Gault equation.

EHR, electronic health record; GFR, glomerular filtration rate.